Black Diamond Therapeutics
Stock Forecast, Prediction & Price Target

Black Diamond Therapeutics Financial Estimates

Black Diamond Therapeutics Revenue Estimates

Black Diamond Therapeutics EBITDA Estimates

Black Diamond Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $438K
Low: $438K
High: $438K
avg. 0%
Avg: $3.89M
Low: $3.89M
High: $3.89M
avg. 788.81%
Avg: $12.91M
Low: $12.91M
High: $12.91M
avg. 231.74%
Avg: $160.38M
Low: $160.38M
High: $160.38M
avg. 1141.83%
Net Income
 
% change YoY
$-123.20M
 
N/A
$-84.52M
 
31.39%
$-82.44M
 
2.45%
Avg: $-109.86M
Low: $-94.94M
High: $-55.82M
avg. -33.26%
Avg: $-135.44M
Low: $-99.77M
High: $-50.54M
avg. -23.28%
Avg: $-98.23M
Low: $-98.23M
High: $-98.23M
avg. 27.46%
Avg: $-50.54M
Low: $-50.54M
High: $-50.54M
avg. 48.54%
EBITDA
 
% change YoY
$-125.59M
 
N/A
$-95.06M
 
24.31%
$-86.02M
 
9.50%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$3.4
 
N/A
-$2.33
 
31.47%
-$1.88
 
19.31%
Avg: -$1.67
Low: -$2.16
High: -$1.27
avg. 11.17%
Avg: -$1.77
Low: -$2.27
High: -$1.15
avg. -6.10%
Avg: -$2.24
Low: -$2.24
High: -$2.24
avg. -26.12%
Avg: -$1.15
Low: -$1.15
High: -$1.15
avg. 48.54%
Operating Expenses
 
% change YoY
$126.87M
 
N/A
$92.82M
 
-26.83%
$86.46M
 
-6.85%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Black Diamond Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 4.86% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is -94.94M, average is -109.86M and high is -55.82M.

What is Black Diamond Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 540.59% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is $438K, average is $438K and high is $438K.

What is Black Diamond Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 6.86% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is -$2.16, average is -$1.67 and high is $-1.27.

What is the best performing analyst?

In the last twelve months analysts have been covering Black Diamond Therapeutics stock. The most successful analyst is Joseph Calanzaro.